|
New NIH-funded data show lower use of most substances continues following the COVID-19 pandemic
News Releases
|
Engagement across stakeholders is critical to accelerate smoking cessation and reduce smoking-related disease and death
Higher doses of buprenorphine may improve treatment outcomes for people with opioid use disorder
|
Suggests higher doses of buprenorphine were associated with lower rates of future emergency department care
Fewer than half of U.S. jails provide life-saving medications for opioid use disorder
|
NIH findings highlight critical gaps in treatment access in correctional facilities for people with SUDs.
Cannabis and hallucinogen use among adults remained at historic highs in 2023
|
Vaping among younger adults and binge drinking among mid-life adults also maintained historically high levels
NIH launches program to advance research led by Native American communities on substance use and pain
|
Aims to elevate Indigenous knowledge and culture in research to respond to the overdose crisis
Doctors reluctant to treat addiction most commonly report “lack of institutional support” as barrier
|
Study highlights need for greater education, training, and policies to support physician intervention in addiction
Most Americans don’t know that primary care physicians can prescribe addiction treatment
| En español
|
Study shows need to increase awareness that medications for opioid use disorder can be prescribed via primary care
Federal study examines care following nonfatal overdose among medicare beneficiaries; identifies effective interventions and gaps in care
| En español
|
Receiving gold-standard care after a non-fatal overdose was associated with a decreased risk of subsequent overdose.
NIH-funded intervention did not impact opioid-related overdose death rates over evaluation period
| En español
|
COVID-19 and increasingly dangerous drugs among factors that may have contributed to diminished impact of intervention
|
NIH-supported study highlights increasingly dangerous illicit drug supply, risk of pills not coming from a pharmacy
Faster approach for starting extended-release naltrexone to treat opioid use disorder shown effective
| En español
|
NIH-supported clinical trial addresses important barrier to opioid use disorder treatment
|
Federal study shows overdose deaths are felt across generations, emphasizing need to support children and families
Analysis of social media language using AI models predicts depression severity for white Americans, but not Black Americans
| En español
|
Black people with depression used different language than white people to express their thoughts on Facebook
|
Psychoactive cannabis product use higher in states without delta-8 regulations or cannabis legalization
|
NIH-supported research highlights need to better understand psilocybin in context of growing psychedelic use
Reduced drug use is a meaningful treatment outcome for people with stimulant use disorders
| En español
|
NIH-supported findings suggest the need to expand definitions of addiction treatment success beyond abstinence
|
Just seven states had a facility that accepted Medicaid, had a bed open the same day, and offered buprenorphine
Semaglutide associated with lower risk of suicidal ideations compared to other treatments prescribed for obesity or type 2 diabetes
| En español
|
Analysis finds patients treated with semaglutide had 49% to 73% lower risk of suicidal ideation
Reported drug use among adolescents continued to hold below pre-pandemic levels in 2023
| En español
|
New data show relatively low use of illicit substances, and yet overdose death rates among teens have risen
Overdose deaths increased in pregnant and postpartum women from early 2018 to late 2021
| En español
|
Among those aged 35 to 44, overdose mortality more than tripled during this period, NIH study reports
Researchers identify brain network that is uniquely activated through injection vs. oral drug use
| En español
|
NIH study suggests the brain’s “salience network” is important for understanding SUD, possible therapeutic target
|
Federally funded study provides evidence supporting expanded use of telehealth services for opioid use disorder
Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder
| En español
|
NIH-funded study suggests need to reevaluate opioid addiction treatment recommendations in the era of fentanyl
Marijuana and hallucinogen use, binge drinking reached historic highs among adults 35 to 50
| En español
|
For younger adults 19 to 30, marijuana, vaping, hallucinogen use are at or near historically high levels
Only 1 in 5 U.S. adults with opioid use disorder received medications to treat it in 2021
| En español
|
NIH and CDC study finds telehealth associated with increased likelihood of receiving evidence-based standard of care
|
NIH study deepens understanding of possible mechanism through which xylazine impacts overdose risk
|
National data show need for more research into the factors underlying differences in sex-based vulnerability to drug use
Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
| En español
|
NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people
NIH and FDA leaders call for more research, lower barriers to improve and implement drug- checking tools amid overdose epidemic
| En español
|
Tools such as fentanyl test strips hold promise to reduce drug-related harms and save lives